With U.S. President Donald Trump’s tariffs, HC Wainwright analyst writes that investors are looking for companies with macroeconomic moats that protect against tariff exposure and regulatory uncertainty.Legend Biotech Corporation LEGN has no material exposure to tariffs, the analyst stated.The cell therapy company’s lead product, Carvykti, is a one-time treatment for relapsed or refractory multiple myeloma, which it develops and markets with collaborator Johnson & Johnson JNJ.Also Read: Johnson & Johnson/ L ...